Penn State are recruiting children 6 to 17 for study of the use of LDN in Crohn's Disease
http://clinicaltrials.gov/ct2/show/N...hn%27s&rank=12
The study is "The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease"
The principal investigator is Prof Jill Smith Past president of The American Pancreas Association
http://fred.psu.edu/ds/retrieve/fred/investigator/jps12
There is research partly funded by JDRF in UK which shows a link between Crohn's and Type 1. See this announcement from Cambridge University
http://www.admin.cam.ac.uk/news/dp/2007060701
Here is the results of previous research done at Penn State in this area
Eighty-nine percent of patients exhibited a response to therapy and 67% achieved a remission (P < 0.001)
http://fred.psu.edu/ds/retrieve/fred...ation/17222320
LDN and Type 1 Facebook group
http://www.facebook.com/group.php?gid=342192490776
http://clinicaltrials.gov/ct2/show/N...hn%27s&rank=12
The study is "The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease"
The principal investigator is Prof Jill Smith Past president of The American Pancreas Association
http://fred.psu.edu/ds/retrieve/fred/investigator/jps12
There is research partly funded by JDRF in UK which shows a link between Crohn's and Type 1. See this announcement from Cambridge University
http://www.admin.cam.ac.uk/news/dp/2007060701
Here is the results of previous research done at Penn State in this area
Eighty-nine percent of patients exhibited a response to therapy and 67% achieved a remission (P < 0.001)
http://fred.psu.edu/ds/retrieve/fred...ation/17222320
LDN and Type 1 Facebook group
http://www.facebook.com/group.php?gid=342192490776